Ram K. Thakur

Lund, M, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Insights from single-cell omics: cellular heterogeneity as a foundation of clinical outcome in chronic myeloid leukemia.

Insights from single-cell omics: cellular heterogeneity as a foundation of clinical outcome in chronic myeloid leukemia.

Journal: Blood
Published: June 20, 2025

Single-cell multiomics analysis of chronic myeloid leukemia links cellular heterogeneity to therapy response.

Single-cell multiomics analysis of chronic myeloid leukemia links cellular heterogeneity to therapy response.

Journal: eLife
Published: November 06, 2024

Concurrent stem- and lineage-affiliated chromatin programs precede hematopoietic lineage restriction.

Concurrent stem- and lineage-affiliated chromatin programs precede hematopoietic lineage restriction.

Journal: Cell reports
Published: October 18, 2023

Concurrent stem- and lineage-affiliated chromatin programs precede hematopoietic lineage restriction.

Concurrent stem- and lineage-affiliated chromatin programs precede hematopoietic lineage restriction.

Journal: Cell reports
Published: April 30, 2020

Non-metastatic 2 (NME2)-mediated suppression of lung cancer metastasis involves transcriptional regulation of key cell adhesion factor vinculin.

Non-metastatic 2 (NME2)-mediated suppression of lung cancer metastasis involves transcriptional regulation of key cell adhesion factor vinculin.

Journal: Nucleic acids research
Published: September 25, 2014

Promoter-proximal transcription factor binding is transcriptionally active when coupled with nucleosome repositioning in immediate vicinity.

Promoter-proximal transcription factor binding is transcriptionally active when coupled with nucleosome repositioning in immediate vicinity.

Journal: Nucleic acids research
Published: August 02, 2014

Functional genomics of lung cancer progression reveals mechanism of metastasis suppressor function.

Functional genomics of lung cancer progression reveals mechanism of metastasis suppressor function.

Journal: Molecular cytogenetics
Published: June 19, 2014

Engineered reversal of drug resistance in cancer cells--metastases suppressor factors as change agents.

Engineered reversal of drug resistance in cancer cells--metastases suppressor factors as change agents.

Journal: Nucleic acids research
Published: October 26, 2013

Lung cancer biomarkers: State of the art.

Lung cancer biomarkers: State of the art.

Journal: Journal of carcinogenesis
Published: July 10, 2012

Metastases suppressor NME2 associates with telomere ends and telomerase and reduces telomerase activity within cells.

Metastases suppressor NME2 associates with telomere ends and telomerase and reduces telomerase activity within cells.

Journal: Nucleic acids research
Published: December 03, 2011
Showing 1-10 of 10

Last Updated: 09/26/2026